We are thrilled to announce the launch of the 12th edition of our Biotech Review of the Year!
2024 was a remarkable year for biotech, with groundbreaking developments in AI and mRNA technologies. From the impact of the EU AI Act to the rise of personalised mRNA vaccines, our latest edition covers it all.
We also delve into what lies ahead in 2025 for the key proposals concerning Supplementary Protection Certificate legislation in Europe.
Don’t miss out on the latest trends and insights in the biotech industry.
Follow this link to download it now!